4//SEC Filing
Gibson Daniel Glenn 4
Accession 0001209191-23-028114
CIK 0001850079other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 8:09 PM ET
Size
5.7 KB
Accession
0001209191-23-028114
Insider Transaction Report
Form 4
Telesis Bio Inc.TBIO
Gibson Daniel Glenn
Chief Technology Officer
Transactions
- Sale
Common Stock
2023-05-04$2.83/sh−1,190$3,363→ 102,083 total
Footnotes (3)
- [F1]Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") and does not represent a discretionary sale by the Reporting Person.
- [F2]Represents the weighted average share price of shares sold in the price range of $2.75 to $2.925 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The reporting person has reported a prior award of RSUs in Table II of Form 4. The total reported in Column 5 includes the 20,910 RSUs previously reported in Table II, and 81,173 shares of common stock.
Documents
Issuer
Telesis Bio Inc.
CIK 0001850079
Entity typeother
Related Parties
1- filerCIK 0001866133
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 8:09 PM ET
- Size
- 5.7 KB